Literature DB >> 14757412

Homing and conversion of murine hematopoietic stem cells to lung.

Mark Dooner1, Jan Cerny, Gerald Colvin, Delia Demers, Jeffrey Pimentel, Deborah Greer, Mehrdad Abedi, Christina McAuliffe, Peter Quesenberry.   

Abstract

The hematopoietic stem cell population, lineage negative-Sca positive (HSC), displays a homing defect into bone marrow (BM) after 48-h exposure to interleukin (IL)-3, IL-6, IL-11, and steel factor [J. Hematother. Stem Cell Res. 11 (2002) 913]. Cytokine treatment of murine marrow leads to reversible alterations in adhesion protein expression, which may explain the changes in homing. We evaluated 3 h homing to nonhematopoietic organs of marrow cells exposed to cytokines for 0, 18, 24, 40 and 48 h. HSC cells from C57BL/6J mice were cultured and labeled with the cytoplasmic fluorescent dye CFSE. We found homed events from uncultured cells in spleen, liver and lung, but no events were seen in duodenum or anterior tibialis muscle. Culture in cytokines led to decreased homing to marrow at 24 and 48 h with parallel changes in spleen homing. There was little variability of homing to liver, however the number, of homed events in lung was markedly increased when 24-h cultured cells were assessed. This was approximately a 10-fold increase compared to the 0 h time point (flow cytometry). Homing was determined by evaluation of frozen section (8 microm) by fluorescent microscopy for spleen, liver, duodenum, anterior tibialis and lung. Data were confirmed by flow cytometry from each organ including marrow. These data indicate the presence of a lung homing "hotspot" at 24 h of cytokine culture; this is a time when the stem progenitors cells are in mid S-phase. Altogether these data suggest that homing of marrow cell to nonmarrow organs may fluctuate with cell cycle transit and that there is a lung homing hotspot in mid-S.

Entities:  

Mesh:

Year:  2004        PMID: 14757412     DOI: 10.1016/j.bcmd.2003.09.014

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  16 in total

1.  Optimization of targeted cell replacement therapy: a new approach for lung disease.

Authors:  Pascal Duchesneau; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

2.  Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation.

Authors:  Jason M Aliotta; Fermin M Sanchez-Guijo; Gerri J Dooner; Kevin W Johnson; Mark S Dooner; Kenneth A Greer; Deborah Greer; Jeffrey Pimentel; Luiz M Kolankiewicz; Napoleon Puente; Sam Faradyan; Paulette Ferland; Elaine L Bearer; Michael A Passero; Mehrdad Adedi; Gerald A Colvin; Peter J Quesenberry
Journal:  Stem Cells       Date:  2007-06-07       Impact factor: 6.277

3.  Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.

Authors:  Jacques Foguenne; Ivano Di Stefano; Olivier Giet; Yves Beguin; André Gothot
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

4.  Cellular phenotype and extracellular vesicles: basic and clinical considerations.

Authors:  Peter J Quesenberry; Laura R Goldberg; Jason M Aliotta; Mark S Dooner; Mandy G Pereira; Sicheng Wen; Giovanni Camussi
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

5.  Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension.

Authors:  Kewal Asosingh; Samar Farha; Alan Lichtin; Brian Graham; Deepa George; Micheala Aldred; Stanley L Hazen; James Loyd; Rubin Tuder; Serpil C Erzurum
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

6.  Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.

Authors:  Jason M Aliotta; Patrick J Keaney; Rod R Warburton; Michael DelTatto; Mark S Dooner; Michael A Passero; Peter J Quesenberry; James R Klinger
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

7.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

Review 8.  The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles.

Authors:  Peter J Quesenberry; Jason M Aliotta
Journal:  Stem Cell Rev       Date:  2008-07-30       Impact factor: 5.739

9.  Gene expression fluctuations in murine hematopoietic stem cells with cell cycle progression.

Authors:  Gerri J Dooner; Gerald A Colvin; Mark S Dooner; Kevin W Johnson; Peter J Quesenberry
Journal:  J Cell Physiol       Date:  2008-03       Impact factor: 6.384

10.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.